OR WAIT null SECS
The HCPLive rheumatoid arthritis page is a comprehensive resource for clinical news and insights on arthritis. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for RA, and more.
April 19, 2024
Article
Most (94%) anti-nucleocapsid positivity was linked to a self-reported COVID-19 infection within the prior 3 months.
April 18, 2024
Results of the SELECT-GCA study demonstrated approximately half of patients with giant cell arteritis treated with upadacitinib plus a steroid tapering regimen were able to achieve sustained remission through week 52.
April 17, 2024
Participants described the intervention as complete and coherent and would recommend this intervention to other patients.
April 15, 2024
Video
S Louis Bridges Jr, MD, PhD, explores the role of artificial intelligence in managing rheumatoid arthritis.
April 14, 2024
Benjamin Smith, DMSc, PA-C, discusses integrative rheumatoid arthritis treatment guidelines.
April 12, 2024
A study found MRI treat-to-target strategy does not help bring RA patients to remission, even when also targeting the absence of osteitis alongside clinical remission.
April 10, 2024
Five barriers to adopting TNF therapeutic drug monitoring emerged among a cohort of experienced rheumatologists.
April 09, 2024
The median survival for triple therapy was longer compared with double therapy (15.1 months vs 9.6 months).
Obesity was linked to a lower likelihood of obtaining response to treatment during the 48-week follow-up period.
April 02, 2024
Exercise was beneficial in functional status for both patients with RA and spondyloarthritis.